OrbiMed Capital GP IV LLC
10% owner at ALEC; 10% owner at Principia Biopharma Inc.; 10% owner at Audentes Therapeutics, Inc., and 4 more
- Sold, on record
- $138M
- Dollars the filings state
- Form 4 sales
- 13
- Latest Aug 7, 2019
- Form 144 notices
- 0
- Proposed sales
- Companies
- 7
- Filed as an executive or holder
Companies
- ALECAlector, Inc.10% owner
- Principia Biopharma Inc.10% owner
- Audentes Therapeutics, Inc.10% owner
- Otonomy, Inc.Director
- Relypsa Inc10% owner
- INTERCEPT PHARMACEUTICALS INCDirector
- Anthera Pharmaceuticals IncDirector, 10% owner
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- Relypsa Inc1.6M shares
- Principia Biopharma Inc.1M shares
- ALEC650,000 shares
- Otonomy, Inc.339,198 shares
- Anthera Pharmaceuticals Inc328,400 shares
- Audentes Therapeutics, Inc.161,431 shares
- INTERCEPT PHARMACEUTICALS INC81,305 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale Relypsa IncPlan not statedSep 17 2014
Sold 94,000 shares at $25.27 ($2.4M)
OrbiMed Capital GP IV LLC, 10% owner
Sold 1.1% of holdings ($226M position)8.9M shares leftFirst sale on recordFiling
- 2 Form 4 sale Relypsa IncPlan not statedMay 18 +243 days
Sold 1.5M shares at $34.13 ($49.7M)
OrbiMed Capital GP IV LLC, 10% owner
Sold 16.5% of holdings ($302M position)7.4M shares leftFiling
- 3 Form 4 sale Otonomy, Inc.Plan not statedNov 19 +185 days
Sold 138,398 shares at $28.62 ($4M)
OrbiMed Capital GP IV LLC, Director
Sold 6.1% of holdings ($64.6M position)2.1M shares leftFirst sale on recordFiling
- 4 Form 4 sale Otonomy, Inc.Plan not statedNov 24 +5 days
Sold 200,800 shares at $28.56 ($5.7M)
OrbiMed Capital GP IV LLC, Director
Sold 9.5% of holdings ($60.5M position)1.9M shares leftFiling
- 5 Form 4 sale Audentes Therapeutics, Inc.Plan not statedSep 7 +653 days
Sold 5,000 shares at $22.35 ($112k)
OrbiMed Capital GP IV LLC, 10% owner
Sold 0.1% of holdings ($107M position)4.8M shares leftFirst sale on recordFiling
- 6 Form 4 sale Audentes Therapeutics, Inc.Plan not statedMar 12 +186 days
Sold 156,431 shares at $34.97 ($5.5M)
OrbiMed Capital GP IV LLC, 10% owner
Sold 4.2% of holdings ($129M position)3.5M shares leftFiling
- 7 Form 4 sale Principia Biopharma Inc.UnusualMay 21 +435 days
Sold 1M shares at $30.25 ($30.3M)
OrbiMed Capital GP IV LLC, 10% owner
Sold 38.4% of holdings ($78.8M position)1.6M shares leftFirst sale on recordFiling
- 8 Form 4 sale ALECPlan not statedAug 7 +78 days
Sold 650,000 shares at $17.90 ($11.6M)
OrbiMed Capital GP IV LLC, 10% owner
Sold 18% of holdings ($64.8M position)3M shares leftFirst sale on recordFiling
Every transaction
Loading transactions…
Sales and notices (13)
| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Aug 7, 2019 | ALEC | 10% owner | Form 4 sale | 650,000 | $11.6M | 18.0% | Plan not stated | SEC |
| May 21, 2019 | Principia Biopharma Inc. | 10% owner | Form 4 sale | 1M | $30.3M | 38.4% | Unusual | SEC |
| Mar 12, 2018 | Audentes Therapeutics, Inc. | 10% owner | Form 4 sale | 156,431 | $5.5M | 4.2% | Plan not stated | SEC |
| Sep 7, 2017 | Audentes Therapeutics, Inc. | 10% owner | Form 4 sale | 5,000 | $112k | 0.1% | Plan not stated | SEC |
| Nov 24, 2015 | Otonomy, Inc. | Director | Form 4 sale | 200,800 | $5.7M | 9.5% | Plan not stated | SEC |
| Nov 19, 2015 | Otonomy, Inc. | Director | Form 4 sale | 138,398 | $4M | 6.1% | Plan not stated | SEC |
| May 18, 2015 | Relypsa Inc | 10% owner | Form 4 sale | 1.5M | $49.7M | 16.5% | Plan not stated | SEC |
| Sep 17, 2014 | Relypsa Inc | 10% owner | Form 4 sale | 94,000 | $2.4M | 1.1% | Plan not stated | SEC |
| Apr 9, 2014 | INTERCEPT PHARMACEUTICALS INC | Director | Form 4 sale | 81,305 | $26M | 4.7% | Plan not stated | SEC |
| Nov 15, 2011 | Anthera Pharmaceuticals Inc | Director, 10% owner | Form 4 sale | 60,000 | $417k | 2.0% | Plan not stated | SEC |
| Jun 10, 2011 | Anthera Pharmaceuticals Inc | Director, 10% owner | Form 4 sale | 100,000 | $810k | 3.2% | Plan not stated | SEC |
| May 26, 2011 | Anthera Pharmaceuticals Inc | Director, 10% owner | Form 4 sale | 39,000 | $333k | Plan not stated | SEC | |
| May 11, 2011 | Anthera Pharmaceuticals Inc | Director, 10% owner | Form 4 sale | 129,400 | $936k | 3.8% | Plan not stated | SEC |